ClinicalTrials.Veeva

Menu

Comparative Effectiveness of Ipsilesional High-frequency rTMS, Contralesional Continuous Burst Theta rTMS, and Sham rTMS, Each Combined With Physiotherapy, in Subacute Ischemic Stroke Upper Limb Recovery : Clinical, Neurophysiological and Radiological

A

Assiut University

Status

Not yet enrolling

Conditions

Stroke
Functional MRI
Repetitive Transcranial Magnetic Stimulation

Treatments

Device: Ipsilesional high frequency rTMS combined with physiotherapy
Device: Sham rTMS + Physiotherapy
Device: Contralesional Continuous Burst Theta rTMS (cTBS) + Physiotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06799312
NeuroRehabStroke2025

Details and patient eligibility

About

To compare the efficacy of lesional high-frequency rTMS, contralesional cTBS, and sham stimulation in improving motor and cognitive recovery in post-stroke patients undergoing physiotherapy.

Full description

Globally, stroke is the second leading cause of both death and disability. In 2020, the global prevalence of all stroke subtypes was 89.13 million cases, with acute ischemic stroke (AIS) comprising 76.47% of these, equating to 68.16 million cases . AIS presents a major global public health concern, given the wide range of disabilities it causes, including cognitive impairments. Survivors of stroke bear a significant burden due to the persistent disability they experience over time . Immediately following a stroke, motor impairments are accompanied by significant alterations in the affected primary motor cortex (M1) - detected by transcranial magnetic stimulation (TMS)- resulting in reduced cortical excitability. This can be evidenced by the absence of recordable motor evoked potentials (MEPs), diminished MEP amplitudes, and increased resting motor threshold (rMT). Additionally, stroke can alter brain connectivity, particularly in terms of functional connectivity, which has implications for recovery. Neuroplasticity plays a crucial role in recovery after stroke, allowing the brain to reorganize and compensate for lost functions. Physiotherapy is a cornerstone of post-stroke rehabilitation, particularly for upper limb recovery and cognitive improvement, with early intervention associated with better outcomes. Repetitive transcranial magnetic stimulation (rTMS) has shown promise in the early stages post-stroke, enhancing motor and cognitive recovery, particularly when applied within two weeks of stroke onset. MEPs can be used to monitor changes in cortical excitability and have been linked to both cognitive and motor recovery. Combining rTMS with diffusion tensor imaging (DTI) allows for the assessment of both functional and structural brain changes, providing a deeper understanding of rTMS's therapeutic effects. DTI, through fractional anisotropy (FA), helps to evaluate white matter integrity, and studies have shown that increased FA correlates with motor recovery, making it a valuable tool in examining the structural changes induced by rTMS in stroke recovery. While high frequency rTMS targeting the ipsilesional motor cortex (M1) has demonstrated efficacy in enhancing motor recovery, contralesional continuous theta-burst stimulation (cTBS) has shown promising results offering an alternative by modulating interhemispheric inhibition. However, no studies have directly compared the efficacy of these two paradigms against each other and sham stimulation in subacute stroke recovery. This study seeks to address this gap by comparing the outcomes of lesional high frequency rTMS, contralesional cTBS, and sham stimulation in combination with physiotherapy.

Enrollment

90 estimated patients

Sex

All

Ages

40 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • First-ever ischemic stroke, confirmed by imaging.
  • Stroke affecting the non-dominant hemisphere (cortical or subcortical) within the middle cerebral artery (MCA) territory.
  • Acute to subacute stage of stroke (time since onset: 48 hours to 2 weeks).
  • Ability to comply with the study protocol and interventions.

Exclusion criteria

  • Hemorrhagic stroke or bilateral stroke.
  • Severe cognitive impairment, defined as a Montreal Cognitive Assessment (MoCA) score < 10.
  • Contraindications to TMS, such as: History of epilepsy, Metallic implants in the head, Other contraindications based on TMS safety guidelines.
  • Comorbid conditions that limit participation in rehabilitation.
  • Severe neglect or aphasia that would impede participation in therapy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

90 participants in 3 patient groups

Ipsilesional high frequency rTMS combined with physiotherapy
Active Comparator group
Description:
rTMS Protocol: Stimulation delivered to the hand area of the ipsilesional primary motor cortex (M1). Frequency: 3 Hz. Stimulation: 2 seconds per train, 37 trains per session. Total pulses: 750 per session at 130% of the resting motor threshold (RMT). Physiotherapy: Patients receive standard physiotherapy sessions.
Treatment:
Device: Ipsilesional high frequency rTMS combined with physiotherapy
Contralesional Continuous Burst Theta rTMS (cTBS) + Physiotherapy
Active Comparator group
Description:
rTMS Protocol: Stimulation delivered to the contralesional primary motor cortex (M1). Protocol: Continuous bursts of 3 stimuli at 50 Hz, repeated at 5 bursts per second. Duration: 40 seconds per session. Stimulation intensity: 70% of RMT with a biphasic TMS-induced current at a 45° angle to the midline. Physiotherapy: Patients receive standard physiotherapy sessions.
Treatment:
Device: Contralesional Continuous Burst Theta rTMS (cTBS) + Physiotherapy
Sham rTMS + Physiotherapy
Sham Comparator group
Description:
Patients receive a sham stimulation designed to mimic rTMS without delivering active magnetic pulses. This maintains blinding for participants and investigators. Physiotherapy: Patients receive standard physiotherapy sessions.
Treatment:
Device: Sham rTMS + Physiotherapy

Trial contacts and locations

0

Loading...

Central trial contact

Mohammad Ahmad Korayem, Assistant lecturer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems